(Q44374816)

2 December 2017

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo (English)

1 reference

2 December 2017

0 references

0 references

1 reference

11

1 reference

2 December 2017

7

Peter Bartenstein

1 reference

2 December 2017

12

Paul Cumming

1 reference

2 December 2017

6

Hans-Georg Buchholz

1 reference

2 December 2017

8

Ole L Munk

1 reference

2 December 2017

2

Ingo Vernaleken

1 reference

2 December 2017

10

Dean F Wong

1 reference

2 December 2017

9

Peter Stoeter

1 reference

2 December 2017

Gerhard Gründer

1

1 reference

2 December 2017

Matthias J Müller

series ordinal

3

1 reference

2 December 2017

Eugen Davids

series ordinal

4

1 reference

2 December 2017

Nilufar Heydari

series ordinal

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

30 October 2002

1 reference

2 December 2017

8

1 reference

inferred from page(s)

published in

Neuropsychopharmacology

1 reference

2 December 2017

28

1 reference

2 December 2017

4

1 reference

2 December 2017

787-794

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300103

2 December 2017

0 references

cites work

Homovanillic acid measurement in clinical research: a review of methodology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

The thalamus and the schizophrenia phenotype: failure to replicate reduced volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

The current status of the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Neurotransmitter interactions in schizophrenia--therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Plasma homovanillic acid as a predictor of response to neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Dopa decarboxylase activity of the living human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Increased dopamine transmission in schizophrenia: relationship to illness phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Left turning (swivel) in medicated chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Elevated thalamic dopamine: possible link to sensory dysfunctions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Elevated dopa decarboxylase activity in living brain of patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Effects of large neutral amino acid concentrations on 6-[F-18]Fluoro-L-DOPA kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Dopamine blockade and clinical response: evidence for two biological subgroups of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

Structural magnetic resonance image averaging in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Plasma homovanillic acid levels and subtyping of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Pharmacokinetics of radiotracers in human plasma during positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Prepulse Inhibition of the Startle Response in Men With Schizophrenia: Effects of Age of Onset of Illness, Symptoms, and Medication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Left-right asymmetry of striatal dopamine D2 receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Rapid Automated Algorithm for Aligning and Reslicing PET Images

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Startle and sensorimotor correlates of ventral thalamic dopamine and GABA in rodents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300103

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300103

1 reference

Dimensions Publication ID

2 December 2017

0 references

1 reference